Diseases of hypothalamic releasing factors

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

The Journal of clinical endocrinology and metabolism·2008

Consensus statement: medical management of acromegaly.

European journal of endocrinology·2005

Diagnosis and treatment of acromegaly complications.

Journal of endocrinological investigation·2004

Growth hormone-releasing hormone and pituitary somatotrope proliferation.

Minerva endocrinologica·2003

The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.

Endocrinology·2001

The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

Endocrinology·2001

Genetic determinants of pregnancy loss: Mechanisms, diagnostic advances, and clinical implications.

Disease-a-month : DM·2026

Disturbances due to cold.

Disease-a-month : DM·2026

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026

Insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026

Primary ciliary dyskinesia in pediatric persons: A microscopic movement malady.

Disease-a-month : DM·2026

Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.

The Pan African medical journal·2026

Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.

Behavioural brain research·2026

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

Molecular immunology·2026

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

Georgian medical news·2026

Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.

Preventive medicine reports·2026

Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.

Frontiers in neuroscience·2026

Related Experiment Videos

Diseases of hypothalamic releasing factors

Related Concept Videos

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

Consensus statement: medical management of acromegaly.

Diagnosis and treatment of acromegaly complications.

Growth hormone-releasing hormone and pituitary somatotrope proliferation.

The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.

The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

Genetic determinants of pregnancy loss: Mechanisms, diagnostic advances, and clinical implications.

Disturbances due to cold.

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Primary ciliary dyskinesia in pediatric persons: A microscopic movement malady.

Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.

Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.

Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.

Related Experiment Videos

Diseases of hypothalamic releasing factors

Related Concept Videos

Related Articles